|
|
|
Scientific Literature, adhesion molecule
Adhesion molecules play an important role in inflammation by determining the ability of cells to adhere to one another, or to the extracellular matrix. The expression patterns of adhesion molecules on cell surfaces have a major influence on how immune cells are recruited to different tissues. One hypothesis about the liver disease of primary sclerosing cholangitis (PSC) is that long-lived mucosal T cells are recruited to the liver in response to aberrantly expressed endothelial-cell adhesion molecules and chemokines that are normally restricted to the gut (Adams et al., 2006).
There have been reports that certain polymorphisms in the intercellular adhesion molecule-1 (ICAM1) gene are associated with inflammatory bowel disease susceptibility (Braun et al., 2001; Low et al., 2004) and protection against primary sclerosing cholangitis (Yang et al., 2004); however Bowlus et al. (2006) were unable to confirm the latter finding.
-
Aarsetoy H, Brugger-Andersen T, Hetland O, Grundt H, Nilsen DW 2006 Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction.
Thromb. Haemost. 95: 329-336.
-
Abdul-Hai A, Hershkoviz R, Weiss L, Lider O, Slavin S 2005 Effect of linomide on adhesion molecules, TNF-alpha, nitrogen oxide, and cell adhesion.
Int. Immunopharmacol. 5: 231-239.
-
Abel M, Cellier C, Kumar N, Cerf-Bensussan N, Schmitz J, Caillat-Zucman S 2006 Adulthood-onset celiac disease is associated with intercellular adhesion molecule-1 (ICAM-1) gene polymorphism.
Hum. Immunol. 67: 612-617.
-
Abeywardena MY, Head RJ 2001 Longchain n-3 polyunsaturated fatty acids and blood vessel function.
Cardiovasc. Res. 52: 361-371.
*
-
Abonia JP, Austen KF, Rollins BJ, Joshi SK, Flavell RA, Kuziel WA, Koni PA, Gurish MF 2005 Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2.
Blood 105: 4308-4313.
*
-
Abreu MT, Plevy S, Sands BE, Weinstein R 2007 Selective leukocyte apheresis for the treatment of inflammatory bowel disease.
J. Clin. Gastroenterol. 41: 874-888.
-
Adam O 2003 Dietary fatty acids and immune reactions in synovial tissue.
Eur. J. Med. Res. 8: 381-387.
-
Adamiec J, Oficjalska-Mlynczak J 2007 Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy.
Przegl. Lek. 64: 389-392.
-
Adamiec-Mroczek J, Oficjalska-Mlynczak J 2008 Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes - role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy.
Graefes Arch. Clin. Exp. Ophthalmol. Aug 6 [Epub ahead of print].
*
-
Adams DH, Afford SC 2002 The role of cholangiocytes in the development of chronic inflammatory liver disease.
Front. Biosci. 7: 276-285.
-
Adams DH, Afford SC 2005 Effector mechanisms of nonsuppurative destructive cholangitis in graft-versus-host disease and allograft rejection.
Semin. Liver Dis. 25: 281-297.
-
Adams DH, Eksteen B 2006 Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease.
Nat. Rev. Immunol. 6: 244-251.
*
-
Adams DH, Eksteen B, Grant A 2007 Entero-hepatic lymphocyte homing and liver manifestations of IBD.
Falk Symposium 162. LIVER CIRRHOSIS: FROM PATHOPHYSIOLOGY TO DISEASE MANAGEMENT. Dresden (Germany) October 13-14, 2007, p. 20-21.
-
Adams DH, Eksteen B, Grant A, Miles A, Lalor T 2005 The molecular regulation of lymphocyte homing between the liver and gut.
Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 54. *
-
Adams DH, Hubscher SG, Fisher NC, Williams A, Robinson M 1996 Expression of E-selectin and E-selectin ligands in human liver inflammation.
Hepatology 24: 533-538.
*
-
Adams DH, Hubscher SG, Shaw J, Johnson GD, Babbs C, Rothlein R, Neuberger JM 1991 Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis.
Hepatology 14: 426-431.
-
Adams DH, Mainolfi E, Burra P, Neuberger JM, Ayres R, Elias E, Rothlein R 1992 Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases.
Hepatology 16: 810-814.
-
Adams JE, Webb MS, Hu X, Staunton D, Barnum SR 2007 Disruption of the beta(2)-integrin CD11d (alpha(D)beta2) gene fails to protect against experimental autoimmune encephalomyelitis.
J. Neuroimmunol. 184: 180-187.
-
Adamska I, Czerwionka-Szaflarska M, Kulwas A, Mierzwa G, Bala G, Rosc D 2007 Value of E-selectin and L-selectin determination in children and youth with inflammatory bowel disease.
Med. Wieku. Rozwoj. 11: 413-418.
-
Afdhal NH, Nunes D 2004 Evaluation of liver fibrosis: a concise review.
Am. J. Gastroenterol. 99: 1160-1174.
*
-
Agarwal R, Agarwal C, Ichikawa H, Singh RP, Aggarwal BB 2006 Anticancer potential of silymarin: from bench to bed side.
Anticancer Res. 26: 4457-4498.
-
Agarwal SK, Brenner MB 2006 Role of adhesion molecules in synovial inflammation.
Curr. Opin. Rheumatol. 18: 268-276.
-
Aggarwal BB, Harikumar KB 2008 Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.
Int. J. Biochem. Cell. Biol. Jul 9 [Epub ahead of print].
*
-
Aggarwal BB, Kunnumakkara AB, Harikumar KB, Tharakan ST, Sung B, Anand P 2008 Potential of spice-derived phytochemicals for cancer prevention.
Planta Med. Jul 8 [Epub ahead of print].
-
Aggarwal BB, Takada Y, Oommen OV 2004 From chemoprevention to chemotherapy: common targets and common goals.
Expert Opin. Investig. Drugs 13: 1327-1338.
-
Ahmed W, Orasanu G, Nehra V, Asatryan L, Rader DJ, Ziouzenkova O, Plutzky J 2006 High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha. A candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion.
Circ. Res. 98: 490-498.
*
-
Ahn KS, Aggarwal BB 2005 Transcription factor NF-kappaB: a sensor for smoke and stress signals.
Ann. N. Y. Acad. Sci. 1056: 218-233.
*
-
Ahuja J, Kampani K, Datta S, Wigdahl B, Flaig KE, Jain P 2006 Use of human antigen presenting cell gene array profiling to examine the effect of human T-cell leukemia virus type 1 Tax on primary human dendritic cells.
J. Neurovirol. 12: 47-59.
-
Ajjan RA, Weetman AP 2004 New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy.
J. Endocrinol. Invest. 27: 237-245.
-
Akahori T, Sho M, Hamada K, Suzaki Y, Kuzumoto Y, Nomi T, Nakamura S, Enomoto K, Kanehiro H, Nakajima Y 2007 Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice.
J. Hepatol. 47: 784-792.
*
-
Al-Mutawa SA, Hegab SM 2004 Behcet's disease.
Clin. Exp. Med. 4: 103-131.
*
-
Albanesi C, Scarponi C, Cavani A, Federici M, Nasorri F, Girolomoni G 2000 Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes.
J. Invest. Dermatol. 115: 81-87.
*
-
Albert MA 2007 Inflammatory biomarkers, race/ethnicity and cardiovascular disease.
Nutr. Rev. 65: S234-S238.
-
Alessandro R, Seidita G, Flugy AM, Damiani F, Russo A, Corrado C, Colomba P, Gullotti L, Buettner R, Bruno L, Leo GD 2007 Role of S128R polymorphism of E-selectin in colon metastasis formation.
Int. J. Cancer 121: 528-535.
*
-
Alexis NE, Brickey WJ, Lay JC, Wang Y, Roubey RA, Ting JP, Peden DB 2008 Development of an inhaled endotoxin challenge protocol for characterizing evoked cell surface phenotype and genomic responses of airway cells in allergic individuals.
Ann. Allergy Asthma Immunol. 100: 206-215.
-
Algood HM, Flynn JL 2004 CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration.
J. Immunol. 173: 3287-3296.
*
-
Alic M 1999 Is exposure to a patient with Crohn's disease an environmental factor for developing the disease.
Gut 45: 631-632.
*
-
Almawi WY, Melemedjian OK 2002 Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids.
J. Mol. Endocrinol. 28: 69-78.
*
-
Almawi WY, Melemedjian OK 2002 Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor.
J. Leukoc. Biol. 71: 9-15.
*
-
Amagai M 2006 Desmoglein, the target molecule in autoimmunity and infection.
Nihon Rinsho Meneki Gakkai Kaishi 29: 325-333.
-
Amagai M 2008 Pemphigus vulgaris and its active disease mouse model.
Curr. Dir. Autoimmun. 10: 167-181.
-
Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB 2008 Curcumin and cancer: an "old-age" disease with an "age-old" solution.
Cancer Lett. 267: 133-164.
*
-
Ando T, Jordan P, Wang Y, Itoh M, Joh T, Sasaki M, Elrod JW, Carpenter A, Jennings MH, Minagar A, Alexander JS 2005 MAdCAM-1 expression and regulation in murine colonic endothelial cells in vitro.
Inflamm. Bowel Dis. 11: 258-264.
*
-
Angulo S, Llopis M, Antolin M, Gironella M, Sans M, Malagelada JR, Pique JM, Guarner F, Panes J 2006 Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis.
Am. J. Physiol. Gastrointest. Liver Physiol. 291: G1155-G1162.
*
-
Aoki CA, Borchers AT, Li M, Flavell RA, Bowlus CL, Ansari AA, Gershwin ME 2005 Transforming growth factor beta (TGF-beta) and autoimmunity.
Autoimmun. Rev. 4: 450-459.
-
Aoudjit F, Brochu N, Morin N, Poulin G, Stratowa C, Audette M 1995 Heterodimeric retinoic acid receptor-beta and retinoid X receptor-alpha complexes stimulate expression of the intercellular adhesion molecule-1 gene.
Cell Growth Differ. 6: 515-521.
-
Ara C, Devirgiliis LC, Massimi M 2004 Influence of retinoic acid on adhesion complexes in human hepatoma cells: a clue to its antiproliferative effects.
Cell Commun. Adhes. 11: 13-23.
-
Ardern-Jones MR, Black AP, Bateman EA, Ogg GS 2007 Bacterial superantigen facilitates epithelial presentation of allergen to T helper 2 cells.
Proc. Natl. Acad. Sci. U.S.A. 104: 5557-5562.
*
-
Ardizzone S, Bianchi Porro G 2005 Biologic therapy for inflammatory bowel disease.
Drugs 65: 2253-2286.
-
Arihiro S, Ohtani H, Suzuki M, Murata M, Ejima C, Oki M, Kinouchi Y, Fukushima K, Sasaki I, Nakamura S, Matsumoto T, Torii A, Toda G, Nagura H 2002 Differential expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in ulcerative colitis and Crohn's disease.
Pathol. Int. 52: 367-374.
*
-
Arii S 2004 Role of vascular endothelial growth factor on the invasive potential of hepatocellular carcinoma.
J. Hepatol. 41: 333-335.
*
-
Arikan C, Berdeli A, Kilic M, Tumgor G, Yagci RV, Aydogdu S 2008 Polymorphisms of the ICAM-1 gene are associated with biliary atresia.
Dig. Dis. Sci. 53: 2000-2004.
*
-
Artis D, Humphreys NE, Potten CS, Wagner N, Muller W, McDermott JR, Grencis RK, Else KJ 2000 Beta7 integrin-deficient mice: delayed leukocyte recruitment and attenuated protective immunity in the small intestine during enteric helminth infection.
Eur. J. Immunol. 30: 1656-1664.
*
-
Arzuaga X, Reiterer G, Majkova Z, Kilgore MW, Toborek M, Hennig B 2007 PPARalpha ligands reduce PCB-induced endothelial activation: possible interactions in inflammation and atherosclerosis.
Cardiovasc. Toxicol. 7: 264-272.
-
Asakura H 2002 Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody.
Nippon Rinsho 60: 531-538.
-
Asakura H, Sugimura K 1999 Present states of development in new drugs and treatment of inflammatory bowel disease.
Nippon Rinsho 57: 2490-2495.
-
Asea A 2008 Heat shock proteins and Toll-like receptors.
Handb. Exp. Pharmacol. 183: 111-127.
-
Auth MK, Keitzer RA, Scholz M, Blaheta RA, Hottenrott EC, Herrmann G, Encke A, Markus BH 1993 Establishment and immunological characterization of cultured human gallbladder epithelial cells.
Hepatology 18: 546-555.
-
Ayres RC, Neuberger JM, Shaw J, Joplin R, Adams DH 1993 Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines.
Gut 34: 1245-1249.
*
-
Baadsgaard O, Fisher G, Voorhees JJ, Cooper KD 1990 The role of immune system in the pathogenesis of psoriasis.
J. Invest. Dermatol. 95: 32S-34S.
*
-
Baba N, Kobashi H, Yamamoto K, Terada R, Suzuki T, Hakoda T, Okano N, Shimada N, Fujioka S, Iwasaki Y, Shiratori Y 2006 Gene expression profiling in biliary epithelial cells of primary biliary cirrhosis using laser capture microdissection and cDNA microarray.
Transl. Res. 148: 103-113.
*
-
Bachmann C, Klibanov AL, Olson TS, Sonnenschein JR, Rivera-Nieves J, Cominelli F, Ley KF, Lindner JR, Pizarro TT 2006 Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease.
Gastroenterology 130: 8-16.
*
-
Bae E, Kim WJ, Kang YM, Suk K, Koh EM, Cha HS, Ahn KS, Huh TL, Lee WH 2007 Glucocorticoid-induced tumour necrosis factor receptor-related protein-mediated macrophage stimulation may induce cellular adhesion and cytokine expression in rheumatoid arthritis.
Clin. Exp. Immunol. 148: 410-418.
*
-
Baert FJ, D'Haens GR, Peeters M, Hiele MI, Schaible TF, Shealy D, Geboes K, Rutgeerts PJ 1999 Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.
Gastroenterology 116: 22-28.
*
-
Baeten D, De Keyser F, Veys EM, Theate Y, Houssiau FA, Durez P 2004 Tumour necrosis factor alpha independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules.
Ann. Rheum. Dis. 63: 489-493.
*
-
Baker DE 2007 Natalizumab: overview of its pharmacology and safety.
Rev. Gastroenterol. Disord. 7: 38-46.
-
Baker OJ, Camden JM, Rome DE, Seye CI, Weisman GA 2008 P2Y2 nucleotide receptor activation up-regulates vascular cell adhesion molecular-1 expression and enhances lymphocyte adherence to a human submandibular gland cell line.
Mol. Immunol. 45: 65-75.
*
-
Barbe-Tuana FM, Klein D, Ichii H, Berman DM, Coffey L, Kenyon NS, Ricordi C, Pastori RL 2006 CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets.
Diabetes 55: 2437-2445.
*
-
Bardin N, Reumaux D, Geboes K, Colombel JF, Blot-Chabaud M, Sampol J, Duthilleul P, Dignat-George F 2006 Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease.
Inflamm. Bowel Dis. 12: 16-21.
*
-
Barnes PJ 1997 Nuclear factor-kappa B.
Int. J. Biochem. Cell. Biol. 29: 867-870.
-
Barnich N, Carvalho FA, Glasser AL, Darcha C, Jantscheff P, Allez M, Peeters H, Bommelaer G, Desreumaux P, Colombel JF, Darfeuille-Michaud A 2007 CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease.
J. Clin. Invest. 117: 1566-1574.
*
-
Bartee E, McCormack A, Fruh K 2006 Quantitative membrane proteomics reveals new cellular targets of viral immune modulators.
PLoS Pathog. 2: e107.
*
-
Basu A, Jensen MD, McCann F, Nandy D, Mukhopadhyay D, McConnell JP, Rizza RA 2007 Lack of an effect of pioglitazone or glipizide on lipoprotein-associated phospholipase A2 in type 2 diabetes.
Endocr. Pract. 13: 147-152.
-
Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD 1995 Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia.
J. Invest. Dermatol. 105: 89S-94S.
-
Baumgart DC, Dignass AU 2004 Current biological therapies for inflammatory bowel disease.
Curr. Pharm. Des. 10: 4127-4147.
-
Baumgart DC, Sandborn WJ 2007 Inflammatory bowel disease: clinical aspects and established and evolving therapies.
Lancet 369: 1641-1657.
*
-
Baumgart DC, Wiedenmann B, Dignass AU 2003 Biologic therapy of inflammatory bowel disease.
Z. Gastroenterol. 41: 1017-1032.
-
Becvar R, Stork J, Pesakova V, Stanova A, Hulejova H, Rysova L, Zatloukalova A, Zatloukal P, Jachymova M, Pourova L 2005 Clinical correlations of potential activity markers in systemic sclerosis.
Ann. N. Y. Acad. Sci. 1051: 404-412.
*
-
Beddy DJ, Watson WR, Fitzpatrick JM, O'Connell PR 2004 Critical involvement of stress-activated mitogen-activated protein kinases in the regulation of intracellular adhesion molecule-1 in serosal fibroblasts isolated from patients with Crohn's disease.
J. Am. Coll. Surg. 199: 234-242.
*
-
Bednarczuk T, Gopinath B, Ploski R, Wall JR 2007 Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack?
Clin. Endocrinol. (Oxf.) 67: 3-19.
*
-
Bendjelloul F, Maly P, Mandys V, Jirkovska M, Prokesova L, Tuckova L, Tlaskalova-Hogenova H 2000 Intercellular adhesion molecule-1 (ICAM-1) deficiency protects mice against severe forms of experimentally induced colitis.
Clin. Exp. Immunol. 119: 57-63.
*
-
Bennett JL 2006 Natalizumab and progressive multifocal leukoencephalopathy: migrating towards safe adhesion molecule therapy in multiple sclerosis.
Neurol. Res. 28: 291-298.
-
Berg CL, Gollan JL 1992 Primary biliary cirrhosis: new therapeutic directions.
Scand. J. Gastroenterol. Suppl. 192: 43-49.
-
Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ 2004 Primary biliary cirrhosis: report of a focus study group.
Hepatology 40: 1013-1020.
*
-
Bergman MP, Vandenbroucke-Grauls CM, Appelmelk BJ, D'Elios MM, Amedei A, Azzurri A, Benagiano M, Del Prete G 2005 The story so far: Helicobacter pylori and gastric autoimmunity.
Int. Rev. Immunol. 24: 63-91.
-
Bernstein CN, Sargent M, Gallatin WM 1998 Beta2 integrin/ICAM expression in Crohn's disease.
Clin. Immunol. Immunopathol. 86: 147-160.
-
Berrahmoune H, Herbeth B, Lamont JV, Lambert D, Blankenberg S, Tiret L, Fitzgerald PS, Siest G, Visvikis-Siest S 2007 Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort.
Clin. Chem. Lab. Med. 45: 1339-1346.
-
Berstad P, Seljeflot I, Veierod MB, Hjerkinn EM, Arnesen H, Pedersen JI 2003 Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.
Clin. Sci. (Lond.) 105: 13-20.
*
-
Bertolino P, Schrage A, Bowen DG, Klugewitz K, Ghani S, Eulenburg K, Holz L, Hogg N, McCaughan GW, Hamann A 2005 Early intrahepatic antigen-specific retention of naive CD8(+) T cells is predominantly ICAM-1/LFA-1 dependent in mice.
Hepatology 42: 1063-1071.
*
-
Bezzerri V, Borgatti M, Nicolis E, Lampronti I, Dechecchi MC, Mancini I, Rizzotti P, Gambari R, Cabrini G 2008 Transcription factor oligodeoxynucleotides to NF-kappaB inhibit transcription of IL-8 in bronchial cells.
Am. J. Respir. Cell. Mol. Biol. 39: 86-96.
*
-
Bickston SJ, Comerford LW, Cominelli F 2003 Future therapies for inflammatory bowel disease.
Curr. Gastroenterol. Rep. 5: 518-523.
-
Bird MD, Kovacs EJ 2008 Organ-specific inflammation following acute ethanol and burn injury.
J. Leukoc. Biol. 84: 607-613.
*
-
Bloom S, Fleming K, Chapman R 1995 Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis.
Gut 36: 604-609.
*
-
Bogoevska V, Horst A, Klampe B, Lucka L, Wagener C, Nollau P 2006 CEACAM1, an adhesion molecule of human granulocytes, is fucosylated by fucosyltransferase IX and interacts with DC-SIGN of dendritic cells via LewisX residues.
Glycobiology 16: 197-209.
*
-
Boiardi L, Salvarani C, Casali B, Olivieri I, Ciancio G, Cantini F, Salvi F, Malatesta R, Govoni M, Trotta F, Filippini D, Paolazzi G, Nicoli D, Farnetti E, Macchioni L 2001 Intercellular adhesion molecule-1 gene polymorphisms in Behcet's disease.
J. Rheumatol. 28: 1283-1287.
-
Bokodi G, Treszl A, Kovacs L, Tulassay T, Vasarhelyi B 2007 Dysplasia: a review.
Pediatr. Pulmonol. 42: 954-963.
-
Bonder CS, Norman MU, Swain MG, Zbytnuik LD, Yamanouchi J, Santamaria P, Ajuebor M, Salmi M, Jalkanen S, Kubes P 2005 Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1.
Immunity 23: 153-163.
*
-
Bonventre JV 2007 Pathophysiology of acute kidney injury: roles of potential inhibitors of inflammation.
Contrib. Nephrol. 156: 39-46.
-
Bordet R, Ouk T, Petrault O, Gele P, Gautier S, Laprais M, Deplanque D, Duriez P, Staels B, Fruchart JC, Bastide M 2006 PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases.
Biochem. Soc. Trans. 34: 1341-1346.
*
-
Borska L, Fiala Z, Krejsek J, Andrys C, Vokurkova D, Hamakova K, Kremlacek J, Ettler K 2006 Selected immunological changes in patients with Goeckerman's therapy TNF-alpha, sE-selectin, sP-selectin, sICAM-1 and IL-8.
Physiol. Res. 55: 699-706.
*
-
Bosello S, Santoliquido A, Zoli A, Di Campli C, Flore R, Tondi P, Ferraccioli G 2008 TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis.
Clin. Rheumatol. 27: 833-839.
*
-
Bourges D, Zhan Y, Brady JL, Braley H, Caminschi I, Prato S, Villadangos JA, Lew AM 2007 Targeting the gut vascular endothelium induces gut effector CD8 T cell responses via cross-presentation by dendritic cells.
J. Immunol. 179: 5678-5685.
-
Bowlus CL, Karlsen TH, Broome U, Thorsby E, Vatn M; the IBSEN study group; Schrumpf E, Lie BA, Boberg KM 2006 Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.
J. Hepatol. 45: 704-710.
*
-
Boyle PJ 2007 Diabetes mellitus and macrovascular disease: mechanisms and mediators.
Am. J. Med. 120: S12-S17.
*
-
Brandtzaeg P, Johansen FE 2005 Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties.
Immunol. Rev. 206: 32-63.
*
-
Brannigan AE, Watson RW, Beddy D, Hurley H, Fitzpatrick JM, O'Connell PR 2002 Increased adhesion molecule expression in serosal fibroblasts isolated from patients with inflammatory bowel disease is secondary to inflammation.
Ann. Surg. 235: 507-511.
*
-
Braun C, Zahn R, Martin K, Albert E, Folwaczny C 2001 Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status.
Clin. Immunol. 101: 357-360.
*
-
Breuhahn K, Baeuerle PA, Peters M, Prang N, Tox U, Kohne-Volland R, Dries V, Schirmacher P, Leo E 2006 Expression of epithelial cellular adhesion molecule (Ep-CAM) in chronic (necro-)inflammatory liver diseases and hepatocellular carcinoma.
Hepatol. Res. 34: 50-56.
-
Brick C, Belgnaoui FZ, Atouf O, Aoussar A, Bennani N, Senouci K, Hassam B, Essakalli M 2007 Pemphigus and HLA in Morocco.
Transfus. Clin. Biol. 14: 402-406.
-
Briskin M, Winsor-Hines D, Shyjan A, Cochran N, Bloom S, Wilson J, McEvoy LM, Butcher EC, Kassam N, Mackay CR, Newman W, Ringler DJ 1997 Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue.
Am. J. Pathol. 151: 97-110.
*
-
Brogan PA, Shah V, Klein N, Dillon MJ 2004 Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
Arthritis Rheum. 50: 589-597.
*
-
Broome U, Hauzenberger D, Klominek J 1996 Adhesion molecules in primary biliary cirrhosis and primary sclerosing cholangitis.
Hepatogastroenterology 43: 1109-1112.
-
Broome U, Hultcrantz R, Scheynius A 1993 Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis.
Scand. J. Gastroenterol. 28: 126-130.
-
Brown TR, Stonehouse TJ, Branch JS, Brickell PM, Katz DR 1997 Stable transfection of U937 cells with sense or antisense RXR-alpha cDNA suggests a role for RXR-alpha in the control of monoblastic differentiation induced by retinoic acid and vitamin D.
Exp. Cell Res. 236: 94-102.
*
-
Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A 2003 Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms.
J. Immunol. 171: 6164-6172.
*
-
Brzoska T, Luger TA, Maaser C, Abels C, Bohm M 2008 alpha-Melanocyte-stimulating hormone and related tripeptides: biochemistry, anti-inflammatory and protective effects in vitro and in vivo and future perspectives for the treatment of immune-mediated inflammatory diseases.
Endocr. Rev. 29: 581-602.
*
-
Buckingham RE 2005 Thiazolidinediones: pleiotropic drugs with potent anti-inflammatory properties for tissue protection.
Hepatol. Res. 33: 167-170.
-
Bullard DC, Hu X, Adams JE, Schoeb TR, Barnum SR 2007 p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis.
Am. J. Pathol. 170: 2001-2008.
*
-
Bullard DC, Hu X, Schoeb TR, Collins RG, Beaudet AL, Barnum SR 2007 Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis.
J. Immunol. 178: 851-857.
*
-
Burleson GR, Burleson FG 2008 Testing human biologicals in animal host resistance models.
J. Immunotoxicol. 5: 23-31.
-
Calabro P, Samudio I, Safe SH, Willerson JT, Yeh ET 2005 Inhibition of tumor-necrosis-factor-alpha-induced endothelial cell activation by a new class of PPAR-gamma agonists.
J. Vasc. Res. 42: 509-516.
-
Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Van der Saag PT 1995 Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
Mol. Endocrinol. 9: 401-412.
*
-
Calder PC 2002 Dietary modification of inflammation with lipids.
Proc. Nutr. Soc. 61: 345-358.
*
-
Calder PC 2003 n-3 Polyunsaturated fatty acids and inflammation: from molecular biology to the clinic.
Lipids 38: 343-352.
-
Calder PC 2004 n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored.
Clin. Sci. (Lond.) 107: 1-11.
*
-
Calder PC 2006 Polyunsaturated fatty acids and inflammation.
Prostaglandins Leukot. Essent. Fatty Acids 75: 197-202.
*
-
Calder PC 2006 n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases.
Am. J. Clin. Nutr. 83: 1505S-1519S.
*
-
Calder PC 1998 Immunoregulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids.
Braz. J. Med. Biol. Res. 31: 467-490.
*
-
Calder PC 2005 Polyunsaturated fatty acids and inflammation.
Biochem. Soc. Trans. 33: 423-427.
*
-
Calderon-Garciduenas L, Villarreal-Calderon R, Valencia-Salazar G, Henriquez-Roldan C, Gutierrez-Castrellon P, Torres-Jardon R, Osnaya-Brizuela N, Romero L, Torres-Jardon R, Solt A, Reed W 2008 Systemic inflammation, endothelial dysfunction, and activation in clinically healthy children exposed to air pollutants.
Inhal. Toxicol. 20: 499-506.
-
Calkin AC, Allen TJ, Lassila M, Tikellis C, Jandeleit-Dahm KA, Thomas MC 2007 Increased atherosclerosis following treatment with a dual PPAR agonist in the ApoE knockout mouse.
Atherosclerosis 195: 17-22.
-
Callaghan MJ, Rockett K, Banner C, Haralambous E, Betts H, Faust S, Maiden MC, Kroll JS, Levin M, Kwiatkowski DP, Pollard AJ 2008 Haplotypic diversity in human CEACAM genes: effects on susceptibility to meningococcal disease.
Genes Immun. 9: 30-37.
*
-
Campbell DJ, Butcher EC 2002 Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues.
J. Exp. Med. 195: 135-141.
*
-
Campbell DJ, Debes GF, Johnston B, Wilson E, Butcher EC 2003 Targeting T cell responses by selective chemokine receptor expression.
Semin. Immunol. 15: 277-286.
*
-
Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P, Andrew DP, Warnke R, Ruffing N, Kassam N, Wu L, Butcher EC 1999 The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells.
Nature 400: 776-780.
*
-
Campbell JJ, Murphy KE, Kunkel EJ, Brightling CE, Soler D, Shen Z, Boisvert J, Greenberg HB, Vierra MA, Goodman SB, Genovese MC, Wardlaw AJ, Butcher EC, Wu L 2001 CCR7 expression and memory T cell diversity in humans.
J. Immunol. 166: 877-884.
*
-
Campbell S, Burkly LC, Gao HX, Berman JW, Su L, Browning B, Zheng T, Schiffer L, Michaelson JS, Putterman C 2006 Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.
J. Immunol. 176: 1889-1898.
*
-
Capsoni F, Ongari A, Colombo G, Turcatti F, Catania A 2007 The synthetic melanocortin (CKPV)(2) exerts broad anti-inflammatory effects in human neutrophils.
Peptides 28: 2016-2022.
*
-
Carfi' M, Croera C, Ferrario D, Campi V, Bowe G, Pieters R, Gribaldo L 2008 TBTC induces adipocyte differentiation in human bone marrow long term culture.
Toxicology 249: 11-18.
*
-
Carpentier PA, Getts MT, Miller SD 2008 Pro-inflammatory functions of astrocytes correlate with viral clearance and strain-dependent protection from TMEV-induced demyelinating disease.
Virology 375: 24-36.
-
Casos K, Saiz MP, Ruiz-Sanz JI, Mitjavila MT 2008 Atherosclerosis prevention by a fish oil-rich diet in apoE(-/-) mice is associated with a reduction of endothelial adhesion molecules.
Atherosclerosis Mar 16 [Epub ahead of print].
-
Cayrol R, Wosik K, Berard JL, Dodelet-Devillers A, Ifergan I, Kebir H, Haqqani AS, Kreymborg K, Krug S, Moumdjian R, Bouthillier A, Becher B, Arbour N, David S, Stanimirovic D, Prat A 2008 Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system.
Nat. Immunol. 9: 137-145.
*
-
Cazzola R, Russo-Volpe S, Miles EA, Rees D, Banerjee T, Roynette CE, Wells SJ, Goua M, Wahle KW, Calder PC, Cestaro B 2007 Age- and dose-dependent effects of an eicosapentaenoic acid-rich oil on cardiovascular risk factors in healthy male subjects.
Atherosclerosis 193: 159-167.
-
Cellier C, Patey N, Fromont-Hankard G, Cervoni JP, Leborgne M, Chaussade S, Barbier JP, Brousse N 1997 In-situ endothelial cell adhesion molecule expression in ulcerative colitis. E-selectin in-situ expression correlates with clinical, endoscopic and histological activity and outcome.
Eur. J. Gastroenterol. Hepatol. 9: 1197-1203.
-
Chabas D 2006 Recent advances in the immunology of multiple sclerosis.
Rev. Neurol. (Paris) 162: 162-173.
-
Chae WJ, Henegariu O, Lee SK, Bothwell AL 2006 The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells.
Proc. Natl. Acad. Sci. U.S.A. 103: 9631-9636.
*
-
Chang TT, Hughes-Fulford M 2008 Monolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypes.
Tissue Eng. Part A. Aug 26 [Epub ahead of print].
-
Chanson M, Berclaz PY, Scerri I, Dudez T, Wernke-Dollries K, Pizurki L, Pavirani A, Fiedler MA, Suter S 2001 Regulation of gap junctional communication by a pro-inflammatory cytokine in cystic fibrosis transmembrane conductance regulator-expressing but not cystic fibrosis airway cells.
Am. J. Pathol. 158: 1775-1784.
*
-
Chapman RW 2003 The management of primary sclerosing cholangitis.
Curr. Gastroenterol. Rep. 5: 9-17.
-
Chavakis E, Hain A, Vinci M, Carmona G, Bianchi ME, Vajkoczy P, Zeiher AM, Chavakis T, Dimmeler S 2007 High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells.
Circ. Res. 100: 204-212.
*
-
Chedid A, Mendenhall CL, Moritz TE 1999 The antigenic heterogeneity of the bile duct epithelium in alcoholic liver disease. VA Cooperative Study Group 275.
Arch. Pathol. Lab. Med. 123: 411-414.
*
-
Chen F 2004 Endogenous inhibitors of nuclear factor-kappaB, an opportunity for cancer control.
Cancer Res. 64: 8135-8138.
*
-
Chen G, Shi J, Hu Z, Hang C 2008 Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential neuroprotective mechanism of N-acetylcysteine.
Mediators Inflamm. 2008: 716458.
*
-
Chen H, Cui B, Wang S, Zhao Z, Sun H, Gu X, Zhao Y, Li X, Ning G 2008 The common variants of E-selectin gene in Graves' disease.
Genes Immun. 9: 182-186.
*
-
Chen J, Fujimoto C, Vistica BP, Wawrousek EF, Kelsall B, Gery I 2006 Active participation of antigen-nonspecific lymphoid cells in immune-mediated inflammation.
J. Immunol. 177: 3362-3368.
*
-
Chen W, Esselman WJ, Jump DB, Busik JV 2005 Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells.
Invest. Ophthalmol. Vis. Sci. 46: 4342-4347.
*
-
Chen W, Jump DB, Esselman WJ, Busik JV 2007 Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid.
Invest. Ophthalmol. Vis. Sci. 48: 18-26.
*
-
Chen Y, Gan H, Ouyang Q, Xu D, Pan Y 2004 The effects of anti-inflammatory on activation of nuclear factor-kappaB and expression of cell adhesion molecules in patients with ulcerative colitis.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 21: 732-736.
-
Chen YH, Lin SJ, Chen YL, Liu PL, Chen JW 2006 Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules.
Cardiovasc. Hematol. Disord. Drug Targets 6: 279-304.
-
Cheon JH, Kim JS, Kim JM, Kim N, Jung HC, Song IS 2006 Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking IkappaB kinase and ameliorates acute murine colitis.
Inflamm. Bowel Dis. 12: 1152-1161.
*
-
Cheung PF, Wong CK, Ip WK, Lam CW 2006 IL-25 regulates the expression of adhesion molecules on eosinophils: mechanism of eosinophilia in allergic inflammation.
Allergy 61: 878-885.
*
-
Chiba H, Osanai M, Murata M, Kojima T, Sawada N 2008 Transmembrane proteins of tight junctions.
Biochim. Biophys. Acta 1778: 588-600.
*
-
Chidlow Jr JH, Shukla D, Grisham MB, Kevil CG 2007 Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues.
Am. J. Physiol. Gastrointest. Liver Physiol. 293: G5-G18.
*
-
Chiu WC, Hou YC, Yeh CL, Hu YM, Yeh SL 2007 Effect of dietary fish oil supplementation on cellular adhesion molecule expression and tissue myeloperoxidase activity in diabetic mice with sepsis.
Br. J. Nutr. 97: 685-691.
*
-
Chiu WC, Wang YC, Chien YW, Hou YC, Hu YM, Yeh SL 2008 Effects of dietary fish oil supplementation on cellular adhesion molecule expression and tissue myeloperoxidase activity in hypercholesterolemic mice with sepsis.
J. Nutr. Biochem. Jul 3 [Epub ahead of print].
*
-
Chmaisse HN, Fakhoury HA, Salti NN, Makki RF 2006 The ICAM-1 469 T/C gene polymorphism but not 241 G/A is associated with Behcets disease in the Lebanese population.
Saudi Med. J. 27: 604-607.
-
Choi HJ, Huber AH, Weis WI 2006 Thermodynamics of beta -catenin-ligand interactions. The roles of the N- and C-terminal tails in modulating binding affinity.
J. Biol. Chem. 281: 1027-1038.
*
-
Chung Moh M, Hoon Lee L, Shen S 2005 Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma.
J. Hepatol. 42: 833-841.
*
-
Cieslik P, Hrycek A, Klucinski P 2008 Vasculopathy and vasculitis in systemic lupus erythematosus.
Pol. Arch. Med. Wewn. 118: 57-63.
-
Clark PR, Pober JS, Kluger MS 2008 Knockdown of TNFR1 by the sense strand of an ICAM-1 siRNA: dissection of an off-target effect.
Nucleic Acids Res. 36: 1081-1097.
*
-
Clerico M, Contessa G, Durelli L 2007 Interferon-beta(1a) for the treatment of multiple sclerosis.
Expert Opin. Biol. Ther. 7: 535-542.
-
Cohen IR 2004 Functional immunomics and immune homeostasis.
Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 21. *
-
Cohen RD 2002 Evolving medical therapies for ulcerative colitis.
Curr. Gastroenterol. Rep. 4: 497-505.
-
Cole DK, Gao GF 2004 CD8: adhesion molecule, co-receptor and immuno-modulator.
Cell. Mol. Immunol. 1: 81-88.
*
-
Collino M, Aragno M, Mastrocola R, Benetti E, Gallicchio M, Dianzani C, Danni O, Thiemermann C, Fantozzi R 2006 Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643.
Free Radic. Biol. Med. 41: 579-589.
-
Colone M, Calcabrini A, Toccacieli L, Bozzuto G, Stringaro A, Gentile M, Cianfriglia M, Ciervo A, Caraglia M, Budillon A, Meo G, Arancia G, Molinari A 2008 The multidrug transporter P-glycoprotein: a mediator of melanoma invasion?
J. Invest. Dermatol. 128: 957-971.
*
-
Combarros O, Infante J, Rodriguez E, Llorca J, Pena N, Fernandez-Viadero C, Berciano J 2005 CD14 receptor polymorphism and Alzheimer's disease risk.
Neurosci. Lett. 380: 193-196.
*
-
Cook-Mills JM, Johnson JD, Deem TL, Ochi A, Wang L, Zheng Y 2004 Calcium mobilization and RAC1 activation are required for VCAM-1-stimulated NADPH oxidase activity.
Biochem. J. 378: 539-547.
*
-
Coppi LC, Thomazzi SM, Ayrizono MD, Coy CS, Fagundes JJ, Goes JR, Franchi GC Jr, Nowill AE, Montes CG, Antunes E, Ferraz JG 2007 Comparative study of eosinophil chemotaxis, adhesion, and degranulation in vitro in ulcerative colitis and Crohn's disease.
Inflamm. Bowel Dis. 13: 211-218.
*
-
Cortesini R, Suciu-Foca N 2006 ILT3+ ILT4+ tolerogenic endothelial cells in transplantation.
Transplantation 82 Suppl. 1: S30-S32.
-
Corvino CL, Mamoni RL, Fagundes GZ, Blotta MH 2007 Serum interleukin-18 and soluble tumour necrosis factor receptor 2 are associated with disease severity in patients with paracoccidioidomycosis.
Clin. Exp. Immunol. 147: 483-490.
*
-
Cottone M, Cipolla C, Rosselli M 1995 Epidemiology and pathogenesis of Crohn's disease.
Chir. Ital. 47: 1-7.
-
Cournu-Rebeix I, Genin E, Lesca G, Azoulay-Cayla A, Tubridy N, Noe E, Clanet M, Edan G, Clerget-Darpoux F, Semana G, Fontaine B 2003 Intercellular adhesion molecule-1: a protective haplotype against multiple sclerosis.
Genes Immun. 4: 518-523.
*
-
Csiszar A, Ungvari Z 2004 Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease.
Med. Hypotheses 63: 696-698.
-
Cui T, Schopfer FJ, Zhang J, Chen K, Ichikawa T, Baker PR, Batthyany C, Chacko BK, Feng X, Patel RP, Agarwal A, Freeman BA, Chen YE 2006 Nitrated fatty acids: endogenous anti-inflammatory signaling mediators.
J. Biol. Chem. 281: 35686-35698.
*
-
Cunningham-Rundles S 2001 Nutrition and the mucosal immune system.
Curr. Opin. Gastroenterol. 17: 171-176.
-
Cuzzocrea S 2003 Emerging biotherapies for inflammatory bowel disease.
Expert Opin. Emerg. Drugs 8: 339-347.
-
Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muia C, Caputi AP 2004 WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock.
Shock 22: 340-346.
*
-
Cuzzocrea S, Mazzon E, Di Paola R, Patel NS, Genovese T, Muia C, De Sarro A, Thiemermann C 2004 Erythropoietin reduces the development of experimental, inflammatory bowel disease.
J. Pharmacol. Exp. Ther. 311: 1272-1280.
*
-
Cuzzocrea S, Mazzon E, Genovese T, Crisafulli C, Min WK, Di Paola R, Muia C, Li JH, Malleo G, Xu W, Massuda E, Esposito E, Zhang J, Wang ZQ 2007 Role of poly(ADP-ribose) glycohydrolase in the development of inflammatory bowel disease in mice.
Free Radic. Biol. Med. 42: 90-105.
-
Cuzzocrea S, McDonald MC, Mazzon E, Mota-Filipe H, Centorrino T, Terranova ML, Ciccolo A, Britti D, Caputi AP, Thiemermann C 2001 Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat.
Gut 48: 478-488.
*
-
Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C 2003 Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Br. J. Pharmacol. 140: 366-376.
*
-
Cuzzocrea S, Rossi A, Mazzon E, Di Paola R, Genovese T, Muia C, Caputi AP, Sautebin L 2005 5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration.
Lab. Invest. 85: 808-822.
*
-
Czupryniak L, Mlynarski W, Pawlowski M, Saryusz-Wolska M, Borkowska A, Klich I, Bodalski J, Loba J 2008 Circadian blood pressure variation in normotensive type 2 diabetes patients and angiotensin converting enzyme polymorphism.
Diabetes Res. Clin. Pract. 80: 386-391.
-
D'Haens G, Daperno M 2006 Advances in biologic therapy for ulcerative colitis and Crohn's disease.
Curr. Gastroenterol. Rep. 8: 506-512.
-
Dai SM, Matsuno H, Nakamura H, Nishioka K, Yudoh K 2004 Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
Arthritis Rheum. 50: 432-443.
*
-
Dai SM, Shan ZZ Dr, Xu H, Nishioka K 2007 Cellular targets of interleukin-18 in rheumatoid arthritis.
Ann. Rheum. Dis. 66: 1411-1418.
-
Damsgaard CT, Frokiaer H, Andersen AD, Lauritzen L 2008 Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men.
J. Nutr. 138: 1061-1066.
*
-
Danese S, Semeraro S, Armuzzi A, Papa A, Gasbarrini A 2006 Biological therapies for inflammatory bowel disease: research drives clinics.
Mini Rev. Med. Chem. 6: 771-784.
-
Danese S, Semeraro S, Marini M, Roberto I, Armuzzi A, Papa A, Gasbarrini A 2005 Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation.
Dig. Liver Dis. 37: 811-818.
-
Danese S, Sgambato A, Papa A, Scaldaferri F, Pola R, Sans M, Lovecchio M, Gasbarrini G, Cittadini A, Gasbarrini A 2005 Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.
Am. J. Gastroenterol. 100: 886-895.
*
-
Das S, Haddadi A, Veniamin S, Samuel J 2008 Delivery of rapamycin-loaded nanoparticle down regulates ICAM-1 expression and maintains an immunosuppressive profile in human CD34(+) progenitor-derived dendritic cells.
J. Biomed. Mater. Res. A. 85: 983-992.
-
Das UN, Rao AA 2007 Gene expression profile in obesity and type 2 diabetes mellitus.
Lipids Health Dis. 6: 35.
*
-
Day R, Forbes A 1999 Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease.
Lancet 354: 62-65.
*
-
de Caestecker JS 1997 Bile acid therapy and markers of immune-mediated damage in primary biliary cirrhosis.
Eur. J. Gastroenterol. Hepatol. 9: 145-147.
-
De Caterina R, Cybulsky MA, Clinton SK, Gimbrone MA Jr, Libby P 1995 Omega-3 fatty acids and endothelial leukocyte adhesion molecules.
Prostaglandins Leukot. Essent. Fatty Acids 52: 191-195.
-
De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P 1994 The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells.
Arterioscler. Thromb. 14: 1829-1836.
-
De Caterina R, Liao JK, Libby P 2000 Fatty acid modulation of endothelial activation.
Am. J. Clin. Nutr. 71: 213S-223S.
*
-
De Caterina R, Massaro M 2005 Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes.
J. Membr. Biol. 206: 103-116.
*
-
De Geer A, Carlson LM, Kogner P, Levitskaya J 2008 Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma.
Cancer Immunol. Immunother. 57: 731-743.
*
-
De Keyser F, Elewaut D, De Wever N, Bensbaho K, Cuvelier C 1996 The gut associated addressins: lymphocyte homing in the gut.
Baillieres Clin. Rheumatol. 10: 25-39.
-
De Leeuw K, Sanders JS, Stegeman CA, Smit AJ, Kallenberg C, Bijl M 2005 Accelerated atherosclerosis in patients with Wegener's granulomatosis.
Ann. Rheum. Dis. 64: 753-759.
*
-
De Vos M 2002 Intestines and joints: an entity?
Verh. K. Acad. Geneeskd. Belg. 64: 85-99.
-
Dechecchi MC, Nicolis E, Bezzerri V, Vella A, Colombatti M, Assael BM, Mettey Y, Borgatti M, Mancini I, Gambari R, Becq F, Cabrini G 2007 MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells.
Am. J. Respir. Cell. Mol. Biol. 36: 615-624.
*
-
Dela Pena A, Leclercq I, Field J, George J, Jones B, Farrell G 2005 NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis.
Gastroenterology 129: 1663-1674.
*
-
Delaleu N, Jonsson R 2008 Altered fractalkine cleavage results in an organ-specific 17 kDa fractalkine fragment in salivary glands of NOD mice.
Arthritis Res. Ther. 10: 114.
-
Dema B, Martinez A, Polanco I, Maluenda C, Fernandez-Arquero M, de la Concha EG, Urcelay E, Nunez C 2008 ICAM1 R241 is not associated with celiac disease in the Spanish population.
Hum. Immunol. Aug 11 [Epub ahead of print].
-
Demond AL, Starr T, Dustin ML, Groves JT 2006 Control of antigen presentation with a photoreleasable agonist peptide.
J. Am. Chem. Soc. 128: 15354-15355.
*
-
Desai D, Faubion WA, Sandborn WJ 2007 Review article: biological activity markers in inflammatory bowel disease.
Aliment. Pharmacol. Ther. 25: 247-255.
*
-
Descamps V 2006 Efalizumab.
Ann. Dermatol. Venereol. 133: 666-678.
-
Desideri G, Croce G, Tucci M, Passacquale G, Broccoletti S, Valeri L, Santucci A, Ferri C 2003 Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments.
J. Clin. Endocrinol. Metab. 88: 5341-5437.
*
-
Dessein PH, Joffe BI 2006 Suppression of circulating interleukin-6 concentrations is associated with decreased endothelial activation in rheumatoid arthritis.
Clin. Exp. Rheumatol. 24: 161-167.
-
Dilillo DJ, Hamaguchi Y, Ueda Y, Yang K, Uchida J, Haas KM, Kelsoe G, Tedder TF 2008 Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.
J. Immunol. 180: 361-371.
-
Dinarello CA 2002 The IL-1 family and inflammatory diseases.
Clin. Exp. Rheumatol. 20 (5 Suppl. 27): S1-S13.
-
Ding Y, Zhao L, Mei H, Zhang SL, Huang ZH, Duan YY, Ye P 2008 Exploration of Emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathway.
Eur. J. Pharmacol. 590: 377-386.
-
Dippold W, Wittig B, Schwaeble W, Mayet W, Meyer zum Büschenfelde KH 1993 Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells.
Gut 34: 1593-1597.
*
-
Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W 2008 Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality.
Arch. Intern. Med. 168: 1340-1349.
-
Dold S, Laschke MW, Lavasani S, Menger MD, Thorlacius H 2008 Cholestatic liver damage is mediated by lymphocyte function antigen-1-dependent recruitment of leukocytes.
Surgery 144: 385-393.
-
Dona M, Fredman G, Schwab JM, Chiang N, Arita M, Goodarzi A, Cheng G, von Andrian UH, Serhan CN 2008 Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets.
Blood 112: 848-855.
*
-
Drosera M, Facchetti F, Landolfo S, Mondini M, Nyberg F, Parodi A, Santoro A, Zampieri S, Doria A 2006 Role of soluble and cell surface molecules in the pathogenesis of autoimmune skin diseases.
Clin. Exp. Rheumatol. 24: S7-S13.
-
Dudda JC, Simon JC, Martin S 2004 Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets.
J. Immunol. 172: 857-863.
*
-
Dunehoo AL, Anderson M, Majumdar S, Kobayashi N, Berkland C, Siahaan TJ 2006 Cell adhesion molecules for targeted drug delivery.
J. Pharm. Sci. 95: 1856-1872.
*
-
Eberl G, Littman DR 2003 The role of the nuclear hormone receptor RORgammat in the development of lymph nodes and Peyer's patches.
Immunol. Rev. 195: 81-90.
*
-
Ebert LM, Schaerli P, Moser B 2005 Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
Mol. Immunol. 42: 799-809.
*
-
Ebihara N, Chen L, Tokura T, Ushio H, Iwatsu M, Murakami A 2007 Distinct functions between Toll-like receptors 3 and 9 in retinal pigment epithelial cells.
Ophthalmic Res. 39: 155-163.
-
Ebnet K 2008 Organization of multiprotein complexes at cell-cell junctions.
Histochem. Cell Biol. 130: 1-20.
*
-
Edele F, Molenaar R, Gutle D, Dudda JC, Jakob T, Homey B, Mebius R, Hornef M, Martin SF 2008 Cutting edge: instructive role of peripheral tissue cells in the imprinting of T cell homing receptor patterns.
J. Immunol. 181: 3745-3749.
-
Edwards DR, Handsley MM, Pennington CJ 2008 The ADAM metalloproteinases.
Mol. Aspects Med. Aug 15 [Epub ahead of print].
-
Edwards S, Lalor PF, Nash GB, Rainger GE, Adams DH 2005 Lymphocyte traffic through sinusoidal endothelial cells is regulated by hepatocytes.
Hepatology 41: 451-459.
*
-
Eksteen B, Miles A, Curbishley SM, Tselepis C, Grant AJ, Walker LS, Adams DH 2006 Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10.
J. Immunol. 177: 593-603.
*
-
Elangbam CS, Tyler RD, Lightfoot RM 2001 Peroxisome proliferator-activated receptors in atherosclerosis and inflammation - an update.
Toxicol. Pathol. 29: 224-231.
*
-
Elishmereni M, Bachelet I, Levi-Schaffer F 2008 DNAM-1: an amplifier of immune responses as a therapeutic target in various disorders.
Curr. Opin. Investig. Drugs 9: 491-496.
-
Elner SG, Petty HR, Elner VM, Yoshida A, Bian ZM, Yang D, Kindezelskii AL 2005 TLR4 mediates human retinal pigment epithelial endotoxin binding and cytokine expression.
Trans. Am. Ophthalmol. Soc. 103: 126-137.
*
-
Eming R, Hertl M 2006 Immunoadsorption in pemphigus.
Autoimmunity 39: 609-616.
-
Eming R, Nagel A, Wolff-Franke S, Podstawa E, Debus D, Hertl M 2008 Rituximab exerts a dual effect in pemphigus vulgaris.
J. Invest. Dermatol. Jun 19 [Epub ahead of print].
*
-
Engelhardt B 2008 Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines.
J. Neurol. Sci. Jun 21 [Epub ahead of print].
-
Engelhardt B 2006 Molecular mechanisms involved in T cell migration across the blood-brain barrier.
J. Neural. Transm. 113: 477-485.
*
-
Engelhardt B, Ransohoff RM 2005 The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms.
Trends Immunol. 26: 485-495.
*
-
Ensari A, Ager A, Marsh MN, Morgan S, Moriarty K 1993 Observations of the time-course of the inflammatory response of rectal mucosa to gliadin challenge in gluten-sensitive subjects.
Agents Actions 38 Spec. No.: C47-C50.
-
Ensari A, Ager A, Marsh MN, Morgan S, Moriarty KJ 1993 Time-course of adhesion molecule expression in rectal mucosa of gluten-sensitive subjects after gluten challenge.
Clin. Exp. Immunol. 92: 303-307.
*
-
Erickson BM, Thompson NL, Hixson DC 2006 Tightly regulated induction of the adhesion molecule necl-5/CD155 during rat liver regeneration and acute liver injury.
Hepatology 43: 325-334.
*
-
Erlandsson Harris H, Andersson U 2004 Mini-review: the nuclear protein HMGB1 as a proinflammatory mediator.
Eur. J. Immunol. 34: 1503-1512.
*
-
Esposito E, Cuzzocrea S, Meli R 2006 Peroxisome proliferator-activated receptors and shock state.
ScientificWorldJournal 6: 1770-1782.
-
Eugster HP, Frei K, Kopf M, Lassmann H, Fontana A 1998 IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.
Eur. J. Immunol. 28: 2178-2187.
-
Evans EJ, Esnouf RM, Manso-Sancho R, Gilbert RJ, James JR, Yu C, Fennelly JA, Vowles C, Hanke T, Walse B, Hunig T, Sorensen P, Stuart DI, Davis SJ 2005 Crystal structure of a soluble CD28-Fab complex.
Nat. Immunol. 6: 271-279.
*
-
Falkowska-Podstawka M, Wernicki A 2003 Heat shock proteins in health and disease.
Pol. J. Vet. Sci. 6: 61-70.
-
Fan Y, Wang Y, Tang Z, Zhang H, Qin X, Zhu Y, Guan Y, Wang X, Staels B, Chien S, Wang N 2008 Suppression of proinflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells.
Arterioscler. Thromb. Vasc. Biol. 28: 315-321.
-
Farah R, Freidzon L, Sela S, Michelis R, Gross B, Sulla M 2007 Expression of inflammatory mediators in meningitis.
Harefuah. 146: 410-413, 504.
-
Farinati F, Marino D, De Giorgio M, Baldan A, Cantarini M, Cursaro C, Rapaccini G, Del Poggio P, Di Nolfo MA, Benvegnu L, Zoli M, Borzio F, Bernardi M, Trevisani F, for the Italian Liver Cancer (ITALICA) group 2006 Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
Am. J. Gastroenterol. 101: 524-532.
*
-
Farkas SA, Hornung M, Sattler C, Steinbauer M, Anthuber M, Obermeier F, Herfarth H, Schlitt HJ, Geissler EK 2005 Preferential migration of CD62L cells into the appendix in mice with experimental chronic colitis.
Eur. Surg. Res. 37: 115-122.
-
Farrell AM, Dean D, Millard PR, Charnock FM, Wojnarowska F 2006 Cytokine alterations in lichen sclerosus: an immunohistochemical study.
Br. J. Dermatol. 155: 931-940.
*
-
Farstad IN, Halstensen TS, Kvale D, Fausa O, Brandtzaeg P 1997 Topographic distribution of homing receptors on B and T cells in human gut-associated lymphoid tissue: relation of L-selectin and integrin alpha 4 beta 7 to naive and memory phenotypes.
Am. J. Pathol. 150: 187-199.
*
-
Fava G, Glaser S, Francis H, Alpini G 2005 The immunophysiology of biliary epithelium.
Semin. Liver Dis. 25: 251-264.
-
Fearon U, Mullan R, Markham T, Connolly M, Sullivan S, Poole AR, Fitzgerald O, Bresnihan B, Veale DJ 2006 Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
Arthritis Rheum. 54: 3152-3162.
*
-
Feldmann M, Brennan FM, Paleolog E, Cope A, Taylor P, Williams R, Woody J, Maini RN 2004 Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?
Novartis Found. Symp. 256: 53-69.
-
Fernandes G 2008 Progress in nutritional immunology.
Immunol. Res. 40: 244-261.
-
Fickert P, Stoger U, Fuchsbichler A, Moustafa T, Marschall HU, Weiglein AH, Tsybrovskyy O, Jaeschke H, Zatloukal K, Denk H, Trauner M 2007 A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.
Am. J. Pathol. 171: 525-536.
*
-
Fickert P, Wagner M, Marschall HU, Fuchsbichler A, Zollner G, Tsybrovskyy O, Zatloukal K, Liu J, Waalkes MP, Cover C, Denk H, Hofmann AF, Jaeschke H, Trauner M 2006 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
Gastroenterology 130: 465-481.
*
-
Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, Sobke A, Herrmann M, Preissner KT, Vajkoczy P, Augustin HG 2006 Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation.
Nat. Med. 12: 235-239.
*
-
Finke D, Meier D 2006 Molecular networks orchestrating GALT development.
Curr. Top. Microbiol. Immunol. 308: 19-57.
-
Fiocchi C 1997 The immune system in inflammatory bowel disease.
Acta Gastroenterol. Belg. 60: 156-162.
-
Fiocchi C 2006 The multifactorial pathogenesis of IBD.
Falk Symposium 154: INFLAMMATORY BOWEL DISEASE - DIAGNOSTIC AND THERAPEUTIC STRATEGIES, Moscow (Russia), June 9 - 10, 2006, pp. 21-22. *
-
Fiocchi C 1997 Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions.
Am. J. Physiol. 273: G769-G775.
*
-
Fiocchi C, Ina K, Danese S, Leite AZ, Vogel JD 2006 Alterations of mesenchymal and endothelial cells in inflammatory bowel diseases.
Adv. Exp. Med. Biol. 579: 168-176.
-
Fiorucci S, Antonelli E, Distrutti E, Rizzo G, Mencarelli A, Orlandi S, Zanardo R, Renga B, Di Sante M, Morelli A, Cirino G, Wallace JL 2005 Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs.
Gastroenterology 129: 1210-1224.
*
-
Foell D, Wittkowski H, Ren Z, Turton J, Pang G, Daebritz J, Ehrchen J, Heidemann J, Borody T, Roth J, Clancy R 2008 Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
J. Pathol. 216: 183-192.
*
-
Fondevila C, Shen XD, Tsuchiyashi S, Yamashita K, Csizmadia E, Lassman C, Busuttil RW, Kupiec-Weglinski JW, Bach FH 2004 Biliverdin therapy protects rat livers from ischemia and reperfusion injury.
Hepatology 40: 1333-1341.
*
-
Forsberg G, Fahlgren A, Horstedt P, Hammarstrom S, Hernell O, Hammarstrom ML 2004 Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease.
Am. J. Gastroenterol. 99: 894-904.
*
-
Foster CA, Mechtcheriakova D, Storch MK, Balatoni B, Howard LM, Bornancin F, Wlachos A, Sobanov J, Kinnunen A, Baumruker T 2008 FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage.
Brain Pathol. Jun 6 [Epub ahead of print].
-
Fracchia M, Secreto P, Tabone M, Zaffino C, Pera A, Galatola G 2000 Serum interferon gamma in primary biliary cirrhosis: effect of ursodeoxycholic acid and prednisone therapy alone and in combination.
Eur. J. Gastroenterol. Hepatol. 12: 463-468.
-
Frangogiannis NG 2006 The mechanistic basis of infarct healing.
Antioxid. Redox Signal. 8: 1907-1939.
-
Fruntes V, Limosin F 2008 Schizophrenia and viral infection during neurodevelopment: a pathogenesis model?
Med. Sci. Monit. 14: RA71-RA77.
-
Fry JW, Wood KJ 1999 Gene therapy: potential applications in clinical transplantation.
Expert Rev. Mol. Med. 1: 1-20.
*
-
Furst DE, Gaylis N, Bray V, Olech E, Yocum D, Ritter J, Weisman M, Wallace D, Crues J, Khanna D, Eckel G, Yeilding N, Callegari P, Visvanathan S, Rojas J, Hegedus R, George L, Mamun K, Gilmer K, Troum O 2007 Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the OPPOSITE study.
Ann. Rheum. Dis. 66: 893-899.
*
-
Furth EE, Li J, Purev E, Solomon AC, Rogler G, Mick R, Putt M, Zhang T, Somasundaram R, Swoboda R, Herlyn D 2006 Serum antibodies to EpCAM in healthy donors but not ulcerative colitis patients.
Cancer Immunol. Immunother. 55: 528-537.
*
-
Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, Noda T, Kubo A, Tsukita S 2002 Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice.
J. Cell Biol. 156: 1099-1111.
*
-
Gao D, Wagner AH, Fankhaenel S, Stojanovic T, Schweyer S, Panzner S, Hecker M 2005 CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis.
Gut 54: 70-77.
*
-
Garcia-Palacios V, Yeon Chung H, Jin Choi S, Sarmasik A, Kurihara N, Won Lee J, Galson DL, Collins R, Roodman GD 2007 Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing in osteoclast precursors expression of LFA-1 and ICAM-1.
Bone 40: 316-322.
-
Garrido-Urbani S, Bradfield PF, Lee BP, Imhof BA 2008 Vascular and epithelial junctions: a barrier for leucocyte migration.
Biochem. Soc. Trans. 36: 203-211.
*
-
Gassull MA 2004 The role of nutrition in the treatment of inflammatory bowel disease.
Aliment. Pharmacol. Ther. 20 Suppl. 4: 79-83.
*
-
Geboes K 1994 From inflammation to lesion.
Acta Gastroenterol. Belg. 57: 273-284.
-
Geboes K, Rutgeerts P, Opdenakker G, Olson A, Patel K, Wagner CL, Marano CW 2005 Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease.
Curr. Med. Res. Opin. 21: 1741-1754.
-
Gencik M, Meller S, Borgmann S, Sitter T, Menezes Saecker AM, Fricke H, Epplen JT 2000 The association of CD18 alleles with anti-myeloperoxidase subtypes of ANCA-associated systemic vasculitides.
Clin. Immunol. 94: 9-12.
*
-
Genovese T, Mazzon E, Di Paola R, Muia C, Crisafulli C, Malleo G, Esposito E, Cuzzocrea S 2006 Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein.
Immunology 118: 559-570.
*
-
Getting SJ 2006 Targeting melanocortin receptors as potential novel therapeutics.
Pharmacol. Ther. 111: 1-15.
*
-
Gewirtz AT, Sitaraman SV 2005 Technology evaluation: alicaforsen (Isis).
Curr. Opin. Mol. Ther. 7: 273-281.
-
Ghiadoni L, Mosca M, Tani C, Virdis A, Taddei S, Bombardieri S 2008 Clinical and methodological aspects of endothelial function in patients with systemic autoimmune diseases.
Clin. Exp. Rheumatol. 26: 680-687.
-
Ghouleh IA, Magder S 2008 Nicotinamide adenine dinucleotide phosphate (reduced form) oxidase is important for LPS-induced endothelial cell activation.
Shock 29: 553-559.
-
Giacomelli R, Passacantando A, Frieri G, Parzanese I, D'Alo S, Vernia P, Pimpo MT, Petrucci C, Caprilli R, Cifone MG, Tonietti G 1999 Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients.
Clin. Exp. Immunol. 115: 72-77.
*
-
Gionanlis L, Alexopoulos E, Papagianni A, Leontsini M, Memmos D 2008 Fibrotic mechanisms in idiopathic rapidly progressive glomerulonephritis: the role of TGF-beta1 and C5b-9.
Ren. Fail. 30: 239-246.
-
Gironella M, Iovanna JL, Sans M, Gil F, Penalva M, Closa D, Miquel R, Pique JM, Panes J 2005 Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
Gut 54: 1244-1253.
*
-
Giscombe R, Wang XB, Kakoulidou M, Lefvert AK 2006 Characterization of the expanded T-cell populations in patients with Wegener's granulomatosis.
J. Intern. Med. 260: 224-230.
*
-
Go EK, Jung KJ, Kim JY, Yu BP, Chung HY 2005 Betaine suppresses proinflammatory signaling during aging: the involvement of nuclear factor-kappaB via nuclear factor-inducing kinase/IkappaB kinase and mitogen-activated protein kinases.
J. Gerontol. A. Biol. Sci. Med. Sci. 60: 1252-1264.
-
Goebel S, Huang M, Davis WC, Jennings M, Siahaan TJ, Alexander JS, Kevil CG 2006 VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: implications for inflammatory bowel disease.
Am. J. Physiol. Gastrointest. Liver Physiol. 290: G648-G654.
*
-
Goel A, Kunnumakkara AB, Aggarwal BB 2008 Curcumin as "curecumin": from kitchen to clinic.
Biochem. Pharmacol. 75: 787-809.
*
-
Goel R, Boylan B, Gruman L, Newman PJ, North PE, Newman DK 2007 The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet induced-steatohepatitis.
Am. J. Physiol. Gastrointest. Liver Physiol. 293: G1205-G1214.
*
-
Goggins MG, Goh J, O'Connell MA, Weir DG, Kelleher D, Mahmud N 2001 Soluble adhesion molecules in inflammatory bowel disease.
Ir. J. Med. Sci. 170: 107-111.
-
Goke M, Hoffmann JC, Evers J, Kruger H, Manns MP 1997 Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease.
J. Gastroenterol. 32: 480-486.
-
Gollob JA, Li J, Reinherz EL, Ritz J 1995 CD2 regulates responsiveness of activated T cells to interleukin 12.
J. Exp. Med. 182: 721-731.
*
-
Gomariz RP, Juarranz Y, Abad C, Arranz A, Leceta J, Martinez C 2006 VIP-PACAP system in immunity: new insights for multitarget therapy.
Ann. N. Y. Acad. Sci. 1070: 51-74.
*
-
Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE 2003 Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica.
Semin. Arthritis Rheum. 33: 38-48.
*
-
Gonzalez-Gay MA, Garcia-Unzueta MT, De Matias JM, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J, Llorca J 2006 Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis.
Clin. Exp. Rheumatol. 24: 373-379.
-
Goodman RS, Kirton CM, Oostingh GJ, Schon MP, Clark MR, Bradley JA, Taylor CJ 2008 PECAM-1 polymorphism affects monocyte adhesion to endothelial cells.
Transplantation 85: 471-477.
-
Goto A, Arimura Y, Shinomura Y, Imai K, Hinoda Y 2006 Antisense therapy of MAdCAM-1 for trinitrobenzenesulfonic acid-induced murine colitis.
Inflamm. Bowel Dis. 12: 758-765.
*
-
Goua M, Mulgrew S, Frank J, Rees D, Sneddon AA, Wahle KW 2008 Regulation of adhesion molecule expression in human endothelial and smooth muscle cells by omega-3 fatty acids and conjugated linoleic acids: involvement of the transcription factor NF-kappaB?
Prostaglandins Leukot. Essent. Fatty Acids 78: 33-43.
*
-
Grando SA 2004 New approaches to the treatment of pemphigus.
J. Investig. Dermatol. Symp. Proc. 9: 84-91.
*
-
Grant AJ, Goddard S, Ahmed-Choudhury J, Reynolds G, Jackson DG, Briskin M, Wu L, Hubscher SG, Adams DH 2002 Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease.
Am. J. Pathol. 160: 1445-1455.
*
-
Grant AJ, Lalor PF, Hubscher SG, Briskin M, Adams DH 2001 MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease).
Hepatology 33: 1065-1072.
*
-
Gray-Owen SD, Blumberg RS 2006 CEACAM1: contact-dependent control of immunity.
Nat. Rev. Immunol. 6: 433-446.
*
-
Greenfield SM, Hamblin AS, Shakoor ZS, Teare JP, Punchard NA, Thompson RP 1993 Inhibition of leucocyte adhesion molecule upregulation by tumor necrosis factor alpha: a novel mechanism of action of sulphasalazine.
Gut 34: 252-256.
*
-
Greenfield SM, Punchard NA, Teare JP, Thompson RP 1993 Review article: the mode of action of the aminosalicylates in inflammatory bowel disease.
Aliment. Pharmacol. Ther. 7: 369-383.
-
Grimm H, Mayer K, Mayser P, Eigenbrodt E 2002 Regulatory potential of n-3 fatty acids in immunological and inflammatory processes.
Br. J. Nutr. 87 Suppl. 1: S59-S67.
*
-
Grip O, Bredberg A, Lindgren S, Henriksson G 2007 Increased subpopulations of CD16(+) and CD56(+) blood monocytes in patients with active Crohn's disease.
Inflamm. Bowel Dis. 13: 566-572.
*
-
Grundmann S, Hoefer IE, Ulusans S, van Royen N, Schirmer SH, Ozaki CK, Bode C, Piek JJ, Buschmann IR 2005 Anti-tumor necrosis factor-alpha therapies attenuate adaptive arteriogenesis in the rabbit.
Am. J. Physiol. Heart Circ. Physiol. 289: H1497-H1505.
*
-
Guan Y, Jiang Z, Ciric B, Rostami AM, Zhang GX 2008 Upregulation of chemokine receptor expression by IL-10/IL-4 in adult neural stem cells.
Exp. Mol. Pathol. Aug 6 [Epub ahead of print].
*
-
Gullberg E, Leonard M, Karlsson J, Hopkins AM, Brayden D, Baird AW, Artursson P 2000 Expression of specific markers and particle transport in a new human intestinal M-cell model.
Biochem. Biophys. Res. Commun. 279: 808-813.
*
-
Gultekin FA, Kerem M, Tatlicioglu E, Aricioglu A, Unsal C, Bukan N 2007 Leptin treatment ameliorates acute lung injury in rats with cerulein-induced acute pancreatitis.
World J. Gastroenterol. 13: 2932-2938.
*
-
Gulubova MV, Manolova IM, Vlaykova TI, Prodanova M, Jovchev JP 2007 Adhesion molecules in chronic ulcerative colitis.
Int. J. Colorectal Dis. 22: 581-589.
*
-
Gunesacar R, Erken E, Ozer HT, Bozkurt B, Dinkci S, Deveci D 2008 Analysis of vascular endothelial growth factor gene 936 C/T polymorphism in patients with familial Mediterranean fever.
Int. J. Immunogenet. 35: 33-36.
*
-
Guo L, Richardson KS, Tucker LM, Doll MA, Hein DW, Arteel GE 2004 Role of the renin-angiotensin system in hepatic ischemia reperfusion injury in rats.
Hepatology 40: 583-589.
*
-
Gustavsson C, Agardh E, Bengtsson B, Agardh CD 2008 TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
J. Diabetes Complications 22: 309-316.
-
Hacquard-Bouder C, Chimenti MS, Giquel B, Donnadieu E, Fert I, Schmitt A, Andre C, Breban M 2007 Alteration of antigen-independent immunologic synapse formation between dendritic cells from HLA-B27-transgenic rats and CD4+ T cells: Selective impairment of costimulatory molecule engagement by mature HLA-B27.
Arthritis Rheum. 56: 1478-1489.
*
-
Hagerman EM, Chao SH, Dunn JC, Wu BM 2005 Surface modification and initial adhesion events for intestinal epithelial cells.
J. Biomed. Mater. Res. A. 76A: 272-278.
-
Hamano R, Takahashi HK, Iwagaki H, Yoshino T, Nishibori M, Tanaka N 2006 Stimulation of alpha7 nicotinic acetylcholine receptor inhibits CD14 and the Toll-like receptor 4 expression in human monocytes.
Shock 26: 358-364.
*
-
Han MH, Yoon WK, Lee H, Han SB, Lee K, Park SK, Yang KH, Kim HM, Kang JS 2007 Topical application of silymarin reduces chemical-induced irritant contact dermatitis in BALB/c mice.
Int. Immunopharmacol. 7: 1651-1658.
-
Hanauer SB 2004 Medical therapy for ulcerative colitis 2004.
Gastroenterology 126: 1582-1592.
*
-
Hanschen M, Zahler S, Krombach F, Khandoga A 2008 Reciprocal activation between CD4+ T cells and Kupffer cells during hepatic ischemia-reperfusion.
Transplantation 86: 710-718.
-
Hara J, Ohtani H, Matsumoto T, Nakamura S, Kitano A, Arakawa T, Nagura H, Kobayashi K 1997 Expression of costimulatory molecules B7-1 and B7-2 in macrophages and granulomas of Crohn's disease: demonstration of cell-to-cell contact with T lymphocytes.
Lab. Invest. 77: 175-184.
-
Haraguchi G, Suzuki JI, Kosuge H, Ogawa M, Koga N, Muto S, Itai A, Kagechika H, Shudo K, Isobe M 2006 A new RXR agonist, HX630, suppresses intimal hyperplasia in a mouse blood flow cessation model.
J. Mol. Cell. Cardiol. 41: 885-892.
*
-
Harbige LS 2003 Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3.
Lipids 38: 323-341.
-
Hartge MM, Unger T, Kintscher U 2007 The endothelium and vascular inflammation in diabetes.
Diab. Vasc. Dis. Res. 4: 84-88.
-
Hartwig W, Werner J, Warshaw AL, Antoniu B, Fernandez-Del Castillo C, Gebhard MM, Uhl W, Buchler MW 2004 Membrane-bound ICAM-1 is upregulated by trypsin and contributes to leukocyte migration in acute pancreatitis.
Am. J. Physiol. Gastrointest. Liver Physiol. 287: G1194-G1199.
*
-
Harty MW, Papa EF, Huddleston HM, Young E, Nazareth S, Riley CA, Ramm GA, Gregory SH, Tracy TF Jr 2008 Hepatic macrophages promote the neutrophil-dependent resolution of fibrosis in repairing cholestatic rat livers.
Surgery 143: 667-678.
-
Hattori H, Sato H, Ito D, Tanahashi N, Murata M, Saito I, Watanabe K, Suzuki N 2006 A561C polymorphism of E-selectin is associated with ischemic cerebrovascular disease in the Japanese population without diabetes mellitus and hypercholesterolemia.
Brain Res. 1108: 221-223.
-
Haubner F, Lehle K, Munzel D, Schmid C, Birnbaum DE, Preuner JG 2007 Hyperglycemia increases the levels of vascular cellular adhesion molecule-1 and monocyte-chemoattractant-protein-1 in the diabetic endothelial cell.
Biochem. Biophys. Res. Commun. 360: 560-565.
*
-
Haupl T, Yahyawi M, Lubke C, Ringe J, Rohrlach T, Burmester GR, Sittinger M, Kaps C 2007 Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs.
J. Biomol. Screen. 12: 328-340.
-
He X, Schoeb TR, Panoskaltsis-Mortari A, Zinn KR, Kesterson RA, Zhang J, Samuel S, Hicks MJ, Hickey MJ, Bullard DC 2006 Deficiency of P-selectin or P-selectin glycoprotein ligand-1 leads to accelerated development of glomerulonephritis and increased expression of CC chemokine ligand 2 in lupus-prone mice.
J. Immunol. 177: 8748-8756.
*
-
He Y, Wu GD, Sadahiro T, Noh SI, Wang H, Talavera D, Wang H, Vierling JM, Klein AS 2008 Interaction of CD44 and hyaluronic acid enhances biliary epithelial proliferation in cholestatic livers.
Am. J. Physiol. Gastrointest. Liver Physiol. 295: G305-G312.
*
-
Healy DP 2007 Macrolide immunomodulation of chronic respiratory diseases.
Curr. Infect. Dis. Rep. 9: 7-13.
-
Hegde A, Zhang H, Moochhala SM, Bhatia M 2007 Neurokinin-1 receptor antagonist treatment protects mice against lung injury in polymicrobial sepsis.
J. Leukoc. Biol. 82: 678-685.
*
-
Hermoso MA, Cidlowski JA 2003 Putting the brake on inflammatory responses: the role of glucocorticoids.
IUBMB Life 55: 497-504.
-
Herrmann J, Arias M, Van De Leur E, Gressner AM, Weiskirchen R 2004 CSRP2, TIMP-1, and SM22alpha promoter fragments direct hepatic stellate cell-specific transgene expression in vitro, but not in vivo.
Liver Int. 24: 69-79.
*
-
Hettema ME, Bootsma H, Kallenberg CG 2008 Macrovascular disease and atherosclerosis in SSc.
Rheumatology (Oxford) 47: 578-583.
-
Heufelder AE 2000 Pathogenesis of ophthalmopathy in autoimmune thyroid disease.
Rev. Endocr. Metab. Disord. 1: 87-95.
-
Heuschkel RB 2000 New immunologic treatments for inflammatory bowel disease.
Curr. Opin. Gastroenterol. 16: 565-570.
-
Hibi T, Inoue N, Ogata H, Naganuma M 2003 Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.
J. Gastroenterol. 38 Suppl. 15: 36-42.
-
Hibi T, Ohara M, Watanabe M, Kanai T, Takaishi H, Hayashi A, Hosoda Y, Ogata H, Iwao Y, Aiso S, et al 1993 Interleukin 2 and interferon-gamma augment anticolon antibody dependent cellular cytotoxicity in ulcerative colitis.
Gut 34: 788-793.
*
-
Hicks J, Bullard DC 2006 Review of autoimmune (lupus-like) glomerulonephritis in murine models.
Ultrastruct. Pathol. 30: 345-359.
*
-
Hieshima K, Kawasaki Y, Hanamoto H, Nakayama T, Nagakubo D, Kanamaru A, Yoshie O 2004 CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells.
J. Immunol. 173: 3668-3675.
*
-
Hill KA, Wang KL, Stryker SJ, Gupta R, Weinrach DM, Rao MS 2004 Comparative analysis of cell adhesion molecules, cell cycle regulatory proteins, mismatch repair genes, cyclooxygenase-2, and DPC4 in carcinomas arising in inflammatory bowel disease and sporadic colon cancer.
Oncol. Rep. 11: 951-956.
-
Hiramitsu T, Yasuda T, Ito H, Shimizu M, Julovi SM, Kakinuma T, Akiyoshi M, Yoshida M, Nakamura T 2006 Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38.
Rheumatology (Oxford) 45: 824-832.
*
-
Hirano T, Kodama S, Fujita K, Maeda K, Suzuki M 2007 Role of Toll-like receptor 4 in innate immune responses in a mouse model of acute otitis media.
FEMS Immunol. Med. Microbiol. 49: 75-83.
-
Hirv K, Seyfarth M, Uibo R, Kull K, Salupere R, Latza U, Rink L 1999 Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers.
Scand. J. Gastroenterol. 34: 1025-1032.
*
-
Ho J, Kurtz CC, Naganuma M, Ernst PB, Cominelli F, Rivera-Nieves J 2008 A CD8+/CD103high T cell subset regulates TNF-mediated chronic murine ileitis.
J. Immunol. 180: 2573-2580.
-
Hodgson HJ 1998 Pathogenesis of Crohn's disease.
Baillieres Clin. Gastroenterol. 12: 1-17.
-
Hodulik S, Hadi S 2006 Efalizumab: a biological agent for the treatment of psoriasis.
Rev. Recent Clin. Trials 1: 165-168.
-
Hoer S, Smith L, Lehner PJ 2007 MARCH-IX mediates ubiquitination and downregulation of ICAM-1.
FEBS Lett. 581: 45-51.
*
-
Hokari R, Miura S, Fujimori H, Koseki S, Tsuzuki Y, Kimura H, Higuchi H, Serizawa H, Granger DN, Ishii H 1999 Altered migration of gut-derived T lymphocytes after activation with concanavalin A.
Am. J. Physiol. 277: G763-G772.
*
-
Hommes DW 2004 Signalling proteins.
Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 42. May 7-8. *
-
Hooks JJ, Nagineni CN, Hooper LC, Hayashi K, Detrick B 2008 IFN-beta provides immuno-protection in the retina by inhibiting ICAM-1 and CXCL9 in retinal pigment epithelial cells.
J. Immunol. 180: 3789-3796.
-
Hopkins AM, Baird AW, Nusrat A 2004 ICAM-1: targeted docking for exogenous as well as endogenous ligands.
Adv. Drug Deliv. Rev. 56: 763-778.
*
-
Hoth JJ, Hudson WP, Brownlee NA, Yoza BK, Hiltbold EM, Meredith JW, McCall CE 2007 Toll-like receptor 2 participates in the response to lung injury in a murine model of pulmonary contusion.
Shock 28: 447-452.
-
Howell CD, Li J, Chen W 1999 Role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 during nonsuppurative destructive cholangitis in a mouse graft-versus-host disease model.
Hepatology 29: 766-776.
*
-
Howitz M, Krause TG, Simonsen JB, Hoffmann S, Frisch M, Nielsen NM, Robbins J, Schneerson R, Molbak K, Miller MA 2007 Lack of association between group B meningococcal disease and autoimmune disease.
Clin. Infect. Dis. 45: 1327-1334.
*
-
Hreha G, Jefferson DM, Yu CH, Grubman SA, Alsabeh R, Geller SA, Vierling JM 1999 Immortalized intrahepatic mouse biliary epithelial cells: immunologic characterization and immunogenicity.
Hepatology 30: 358-371.
*
-
Hsu CS, Chiu WC, Yeh CL, Hou YC, Chou SY, Yeh SL 2006 Dietary fish oil enhances adhesion molecule and interleukin-6 expression in mice with polymicrobial sepsis.
Br. J. Nutr. 96: 854-860.
*
-
Huang BB, Bonish BK, Chaturvedi V, Qin JZ, Nickoloff BJ 2001 Keratinocyte CDw60 expression is modulated by both a Th-1 type cytokine IFN-gamma and Th-2 cytokines IL-4 and IL-13: relevance to psoriasis.
J. Invest. Dermatol. 116: 305-312.
*
-
Huang TH, Tran VH, Roufogalis BD, Li Y 2007 Gypenoside XLIX, a naturally occurring PPAR-alpha activator, inhibits cytokine-induced vascular cell adhesion molecule-1 expression and activity in human endothelial cells.
Eur. J. Pharmacol. 565: 158-165.
*
-
Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T 2006 Synovial fibroblasts: key players in rheumatoid arthritis.
Rheumatology (Oxford) 45: 669-675.
*
-
Huehn J, Siegmund K, Lehmann JC, Siewert C, Haubold U, Feuerer M, Debes GF, Lauber J, Frey O, Przybylski GK, Niesner U, de la Rosa M, Schmidt CA, Bräuer R, Buer J, Scheffold A, Hamann A 2004 Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells.
J. Exp. Med. 199: 303-313.
*
-
Hung CF, Huang TF, Chen BH, Shieh JM, Wu PH, Wu WB 2008 Lycopene inhibits TNF-alpha-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion.
Eur. J. Pharmacol. 586: 275-282.
*
-
Hurlimann D, Enseleit F, Ruschitzka F 2004 Rheumatoid arthritis, inflammation, and atherosclerosis.
Herz. 29: 760-768.
-
Hussein MR, Fathi NA, El-Din AM, Hassan HI, Abdullah F, Al-Hakeem E, Backer EA 2008 Alterations of the CD4(+), CD8 (+) T cell subsets, interleukins-1beta, IL-10, IL-17, tumor necrosis factor-alpha and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: preliminary observations.
Pathol. Oncol. Res. Apr 8 [Epub ahead of print].
-
Hyun E, Andrade-Gordon P, Steinhoff M, Vergnolle N 2008 Protease-activated receptor-2 activation: a major role in intestinal inflammation.
Gut 57: 1230-1237.
-
Ichikawa H, Takada Y, Shishodia S, Jayaprakasam B, Nair MG, Aggarwal BB 2006 Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaB-regulated gene expression.
Mol. Cancer Ther. 5: 1434-1445.
*
-
Ieta K, Tanaka F, Utsunomiya T, Kuwano H, Mori M 2006 CEACAM6 gene expression in intrahepatic cholangiocarcinoma.
Br. J. Cancer 95: 532-540.
*
-
Iijima H, Neurath MF, Nagaishi T, Glickman JN, Nieuwenhuis EE, Nakajima A, Chen D, Fuss IJ, Utku N, Lewicki DN, Becker C, Gallagher TM, Holmes KV, Blumberg RS 2004 Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1.
J. Exp. Med. 199: 471-482.
*
-
Ikeda S, Kudsk KA, Fukatsu K, Johnson CD, Le T, Reese S, Zarzaur BL 2003 Enteral feeding preserves mucosal immunity despite in vivo MAdCAM-1 blockade of lymphocyte homing.
Ann. Surg. 237: 677-685.
*
-
Ina Y, Sakai K 2005 Activation of immunological network by chronic low-dose-rate irradiation in wild-type mouse strains: analysis of immune cell populations and surface molecules.
Int. J. Radiat. Biol. 81: 721-729.
-
Infante J, Llorca J, Berciano J, Combarros O 2005 Interleukin-8, intercellular adhesion molecule-1 and tumour necrosis factor-alpha gene polymorphisms and the risk for multiple system atrophy.
J. Neurol. Sci. 228: 11-13.
-
Inoue T, Tsuzuki Y, Matsuzaki K, Matsunaga H, Miyazaki J, Hokari R, Okada Y, Kawaguchi A, Nagao S, Itoh K, Mastumoto S, Miura S 2005 Blockade of PSGL-1 attenuates CD14+ monocytic cell recruitment in intestinal mucosa and ameliorates ileitis in SAMP1/Yit mice.
J. Leukoc. Biol. 77: 287-295.
*
-
Ip E, Farrell G, Hall P, Robertson G, Leclercq I 2004 Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice.
Hepatology 39: 1286-1296.
*
-
Isermann B, Bierhaus A, Humpert PM, Rudofsky G, Chavakis T, Ritzel R, Wendt T, Morcos M, Kasperk C, Hamann A, Nawroth PP 2004 AGE-RAGE: a hypothesis or a mechanism?
Herz. 29: 504-509.
-
Ishida Y, Kondo T, Ohshima T, Fujiwara H, Iwakura Y, Mukaida N 2002 A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury.
FASEB J. 16: 1227-1236.
*
-
Ishii K, Yoshida Y, Akechi Y, Sakabe T, Nishio R, Ikeda R, Terabayashi K, Matsumi Y, Gonda K, Okamoto H, Takubo K, Tajima F, Tsuchiya H, Hoshikawa Y, Kurimasa A, Umezawa A, Shiota G 2008 Hepatic differentiation of human bone marrow-derived mesenchymal stem cells by tetracycline-regulated hepatocyte nuclear factor 3beta.
Hepatology 48: 597-606.
-
Ishizuka T, Cheng J, Singh H, Vitto MD, Manthati VL, Falck JR, Schwartzman M 2008 20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells.
J. Pharmacol. Exp. Ther. 324: 103-110.
-
Israelian-Konaraki Z, Reaven PD 2004 Peroxisome proliferator-activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications.
Cardiology 103: 1-9.
-
Ito H 2005 Treatment of Crohn's disease with anti-IL-6 receptor antibody.
J. Gastroenterol. 40 Suppl. 16: 32-34.
-
Ito H 2004 Novel therapy for Crohn's disease targeting IL-6 signalling.
Expert Opin. Ther. Targets 8: 287-294.
-
Ito S, Ito Y, Katagiri H, Suzuki T, Hoka S, Yokomizo T, Shimizu T, Majima M 2008 Leukotriene B4/leukotriene B4 receptor pathway is involved in hepatic microcirculatory dysfunction elicited by endotoxin.
Shock 30: 87-91.
-
Ito S, Yukawa T, Uetake S, Yamauchi M 2007 Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Alcohol Clin. Exp. Res. 31: S83-S87.
*
-
Iwamoto T, Okamoto H, Toyama Y, Momohara S 2008 Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients.
FEBS J. Jul 24 [Epub ahead of print].
*
-
Izmailova ES, Paz N, Alencar H, Chun M, Schopf L, Hepperle M, Lane JH, Harriman G, Xu Y, Ocain T, Weissleder R, Mahmood U, Healy AM, Jaffee B 2007 Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis.
Arthritis Rheum. 56: 117-128.
*
-
Jacques C, Gosset M, Berenbaum F, Gabay C 2006 The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation.
Vitam. Horm. 74C: 371-403.
-
Jaeschke H 1997 Cellular adhesion molecules: regulation and functional significance in the pathogenesis of liver diseases.
Am. J. Physiol. 273: G602-G611.
-
Jaeschke H, Hasegawa T 2006 Role of neutrophils in acute inflammatory liver injury.
Liver Int. 26: 912-919.
*
-
James WG, Hutchinson P, Bullard DC, Hickey MJ 2006 Cerebral leucocyte infiltration in lupus-prone MRL/MpJ-fas mice - roles of intercellular adhesion molecule-1 and P-selectin.
Clin. Exp. Immunol. 144: 299-308.
*
-
Jara LJ, Medina G, Vera-Lastra O 2007 Systemic antiphospholipid syndrome and atherosclerosis.
Clin. Rev. Allergy Immunol. 32: 172-177.
-
Jaruga B, Hong F, Kim WH, Sun R, Fan S, Gao B 2004 Chronic alcohol consumption accelerates liver injury in T cell-mediated hepatitis: alcohol disregulation of NF-kappaB and STAT3 signaling pathways.
Am. J. Physiol. Gastrointest. Liver Physiol. 287: G471-G479.
*
-
Jelinkova L, Tuckova L, Sanchez D, Krupickova S, Pozler O, Nevoral J, Kotalova R, Tlaskalova-Hogenova H 2000 Increased levels of circulating ICAM-1, E-selectin, and IL-2 receptors in celiac disease.
Dig. Dis. Sci. 45: 398-402.
*
-
Jenkins NE, Mwangi TW, Kortok M, Marsh K, Craig AG, Williams TN 2005 A polymorphism of intercellular adhesion molecule-1 is associated with a reduced incidence of nonmalarial febrile illness in Kenyan children.
Clin. Infect. Dis. 41: 1817-1819.
*
-
Jennette JC 2002 Implications for pathogenesis of patterns of injury in small- and medium-sized-vessel vasculitis.
Cleve. Clin. J. Med. 69 Suppl. 2: SII33-SII38.
-
Jensen M, Klehr M, Vogel A, Schmitz S, Tawadros S, Muhlenhoff M, Pluck A, Fischer T, Schomacker K, Schultze JL, Berthold F 2007 One step generation of fully chimeric antibodies using Cgamma1- and Ckappa mutant mice.
J. Immunother. 30: 338-349.
-
Jiang XL, Cui HF 2002 An analysis of 10218 ulcerative colitis cases in China.
World J. Gastroenterol. 8: 158-161.
-
Jin W, Wang H, Ji Y, Hu Q, Yan W, Chen G, Yin H 2008 Increased intestinal inflammatory response and gut barrier dysfunction in Nrf2-deficient mice after traumatic brain injury.
Cytokine Aug 20 [Epub ahead of print].
-
Jockers JJ, Novak N 2006 Different expression of adhesion molecules and tetraspanins of monocytes of patients with atopic eczema.
Allergy 61: 1419-1422.
*
-
Johnson Z, Schwarz M, Power CA, Wells TN, Proudfoot AE 2005 Multi-faceted strategies to combat disease by interference with the chemokine system.
Trends Immunol. 26: 268-274.
*
-
Johnston A, Gudjonsson JE, Sigmundsdottir H, Runar Ludviksson B, Valdimarsson H 2005 The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules.
Clin. Immunol. 114: 154-163.
*
-
Jois SD, Jining L, Nagarajarao LM 2006 Targeting T-cell adhesion molecules for drug design.
Curr. Pharm. Des. 12: 2797-2812.
-
Jones DE, Palmer JM, James OF, Yeaman SJ, Bassendine MF, Diamond AG 1995 T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis.
Hepatology 21: 995-1002.
-
Jones SC, Banks RE, Haidar A, Gearing AJ, Hemingway IK, Ibbotson SH, Dixon MF, Axon AT 1995 Adhesion molecules in inflammatory bowel disease.
Gut 36: 724-730.
*
-
Joosten LA, Radstake TR, Lubberts E, van den Bersselaar LA, van Riel PL, van Lent PL, Barrera P, van den Berg WB 2003 Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.
Arthritis Rheum. 48: 339-347.
*
-
Joplin RE, Neuberger JM 1999 Immunopathology of primary biliary cirrhosis.
Eur. J. Gastroenterol. Hepatol. 11: 587-593.
-
Joshi A, Bauer R, Kuebler P, White M, Leddy C, Compton P, Garovoy M, Kwon P, Walicke P, Dedrick R 2006 An overview of the pharmacokinetics and pharmacodynamics of efalizumab: a monoclonal antibody approved for use in psoriasis.
J. Clin. Pharmacol. 46: 10-20.
*
-
Jun CD, Kim Y, Choi EY, Kim M, Park B, Youn B, Yu K, Choi KS, Yoon KH, Choi SC, Lee MS, Park KI, Choi M, Chung Y, Oh J 2006 Gliotoxin reduces the severity of trinitrobenzene sulfonic acid-induced colitis in mice: evidence of the connection between heme oxygenase-1 and the nuclear factor-kappaB pathway in vitro and in vivo.
Inflamm. Bowel Dis. 12: 619-629.
*
-
Kadl A, Leitinger N 2005 The role of endothelial cells in the resolution of acute inflammation.
Antioxid. Redox Signal. 7: 1744-1754.
-
Kafkala C, Choi J, Zafirakis P, Baltatzis S, Livir-Rallatos C, Rojas B, Foster CS 2006 Mooren ulcer: an immunopathologic study.
Cornea 25: 667-673.
-
Kagawa H, Nomura S, Nagahama M, Ozaki Y, Fukuhara S 2001 Effect of bezafibrate on soluble adhesion molecules and platelet activation markers in patients with connective tissue diseases and secondary hyperlipidemia.
Clin. Appl. Thromb. Hemost. 7: 153-157.
-
Kageyama K, Ikeda H, Sakihara S, Nigawara T, Terui K, Tsutaya S, Matsuda E, Shoji M, Yasujima M, Suda T 2007 A case of thyrotropin-producing pituitary adenoma, accompanied by an increase in anti-thyrotropin receptor antibody after tumor resection.
J. Endocrinol. Invest. 30: 957-961.
-
Kahn P, Ramanujam M, Bethunaickan R, Huang W, Tao H, Madaio MP, Factor SM, Davidson A 2008 Prevention of murine antiphospholipid syndrome by BAFF blockade.
Arthritis Rheum. 58: 2824-2834.
*
-
Kaichi Y, Hideaki W, Kazuya T, Keikichi T 2008 Conditional expression of microRNA against E-selectin inhibits leukocyte-endothelial adhesive interaction under inflammatory condition.
Biochem. Biophys. Res. Commun. 371: 747-751.
*
-
Kalinowska A, Losy J 2006 PECAM-1, a key player in neuroinflammation.
Eur. J. Neurol. 13: 1284-1290.
-
Kamihira T, Shimoda S, Nakamura M, Yokoyama T, Takii Y, Kawano A, Handa M, Ishibashi H, Gershwin ME, Harada M 2005 Biliary epithelial cells regulate autoreactive T cells: implications for biliary-specific diseases.
Hepatology 41: 151-159.
*
-
Kamijo S, Nakajima A, Kamata K, Kurosawa H, Yagita H, Okumura K 2008 Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA.
Rheumatology (Oxford) 47: 442-450.
-
Kamm MA 2006 Review article: biological drugs in Crohn's disease.
Aliment. Pharmacol. Ther. 24 Suppl. 3: 80-89.
*
-
Kammerer S, Roth RB, Reneland R, Marnellos G, Hoyal CR, Markward NJ, Ebner F, Kiechle M, Schwarz-Boeger U, Griffiths LR, Ulbrich C, Chrobok K, Forster G, Praetorius GM, Meyer P, Rehbock J, Cantor CR, Nelson MR, Braun A 2004 Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus.
Cancer Res. 64: 8906-8910.
*
-
Kaneko M, Ono T, Matsubara T, Yamamoto Y, Ikeda H, Yoshiki T, Furukawa S, Nakayama E 2004 Serological identification of endothelial antigens predominantly recognized in Kawasaki disease patients by recombinant expression cloning.
Microbiol. Immunol. 48: 703-711.
*
-
Kanesaka T, Mori M, Hattori T, Oki T, Kuwabara S 2006 Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis.
J. Neurol. Neurosurg. Psychiatry 77: 185-188.
*
-
Kang W, Gomez FE, Lan J, Sano Y, Ueno C, Kudsk KA 2006 Parenteral nutrition impairs gut-associated lymphoid tissue and mucosal immunity by reducing lymphotoxin beta receptor expression.
Ann. Surg. 244: 392-399.
*
-
Kang W, Kudsk KA, Sano Y, Lan J, Yang-Xin F, Gomez FE, Maeshima Y 2007 Effects of lymphotoxin beta receptor blockade on intestinal mucosal immunity.
JPEN J. Parenter. Enteral Nutr. 31: 358-364.
-
Kanno H, Watabe D, Shimizu N, Sawai T 2008 Adhesion of Epstein-Barr virus-positive natural killer cell lines to cultured endothelial cells stimulated with inflammatory cytokines.
Clin. Exp. Immunol. 151: 519-527.
*
-
Kanwar JR 2005 Anti-inflammatory immunotherapy for multiple sclerosis/experimental autoimmune encephalomyelitis (EAE) disease.
Curr. Med. Chem. 12: 2947-2962.
-
Kaser A, Tilg H 2008 Novel therapeutic targets in the treatment of IBD.
Expert Opin. Ther. Targets 12: 553-563.
-
Katagiri H, Ito Y, Ishii K, Hayashi I, Suematsu M, Yamashina S, Murata T, Narumiya S, Kakita A, Majima M 2004 Role of thromboxane derived from COX-1 and -2 in hepatic microcirculatory dysfunction during endotoxemia in mice.
Hepatology 39: 139-150.
*
-
Katayama K, Wada K, Nakajima A, Mizuguchi H, Hayakawa T, Nakagawa S, Kadowaki T, Nagai R, Kamisaki Y, Blumberg RS, Mayumi T 2003 A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model.
Gastroenterology 124: 1315-1324.
*
-
Katoh M 2005 WNT/PCP signaling pathway and human cancer (review).
Oncol. Rep. 14: 1583-1588.
-
Katsuno G, Takahashi HK, Iwagaki H, Sugita S, Mori S, Saito S, Yoshino T, Nishibori M, Tanaka N 2006 The effect of ciprofloxacin on CD14 and Toll-like receptor-4 expression on human monocytes.
Shock 25: 247-253.
*
-
Katz JA 2002 Advances in the medical therapy of inflammatory bowel disease.
Curr. Opin. Gastroenterol. 18: 435-440.
-
Katz JA, Itoh J, Fiocchi C 1999 Pathogenesis of inflammatory bowel disease.
Curr. Opin. Gastroenterol. 15: 291.
-
Kaur G, Rapthap CC, Kumar S, Bhatnagar S, Bhan MK, Mehra NK 2006 Polymorphism in L-selectin, E-selectin and ICAM-1 genes in Asian Indian pediatric patients with celiac disease.
Hum. Immunol. 67: 634-638.
-
Kavanaugh A 1999 An overview of immunomodulatory intervention in rheumatoid arthritis.
Drugs Today (Barc.) 35: 275-286.
-
Kawachi S, Morise Z, Jennings SR, Conner E, Cockrell A, Laroux FS, Chervenak RP, Wolcott M, van der Heyde H, Gray L, Feng L, Granger DN, Specian RA, Grisham MB 2000 Cytokine and adhesion molecule expression in SCID mice reconstituted with CD4+ T cells.
Inflamm. Bowel Dis. 6: 171-180.
*
-
Kawaguchi M, Kokubu F, Kuga H, Matsukura S, Hoshino H, Ieki K, Imai T, Adachi M, Huang SK 2001 Modulation of bronchial epithelial cells by IL-17.
J. Allergy Clin. Immunol. 108: 804-809.
*
-
Kawana H, Karaki H, Higashi M, Miyazaki M, Hilberg F, Kitagawa M, Harigaya K 2008 CD44 suppresses TLR-mediated inflammation.
J. Immunol. 180: 4235-4245.
-
Kawanokuchi J, Shimizu K, Nitta A, Yamada K, Mizuno T, Takeuchi H, Suzumura A 2008 Production and functions of IL-17 in microglia.
J. Neuroimmunol. 194: 54-61.
-
Keeley KA, Rivey MP, Allington DR 2005 Natalizumab for the treatment of multiple sclerosis and Crohn's disease.
Ann. Pharmaco
| |